Vonoprazan-Based Regimen Is More Useful than PPI-Based One as a First-Line Helicobacter pylori Eradication: A Randomized Controlled Trial

Background. A new agent, potassium-competitive acid blocker vonoprazan (VPZ) has potent acid-inhibitory effects and may offer advantages over conventional H. pylori eradication therapies. We aimed to compare the eradication rate between VPZ-based treatment and PPI-based one. Methods. This randomized...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Can J Gastroenterol Hepatol
Prif Awduron: Maruyama, Masafumi, Tanaka, Naoki, Kubota, Daisuke, Miyajima, Masayuki, Kimura, Takefumi, Tokutake, Koujiro, Imai, Ryujiro, Fujisawa, Toru, Mori, Hiromitsu, Matsuda, Yoshiaki, Wada, Shuichi, Horiuchi, Akira, Kiyosawa, Kendo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2017
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5350398/
https://ncbi.nlm.nih.gov/pubmed/28349044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4385161
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg